Amir Heshmatpour Purchases 37,000 Shares of Neonc Technologies (NASDAQ:NTHI) Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour acquired 37,000 shares of the company’s stock in a transaction dated Friday, September 11th. The stock was acquired at an average price of $3.67 per share, for a total transaction of $135,790.00. Following the acquisition, the chief executive officer owned 3,133,000 shares in the company, valued at approximately $11,498,110. The trade was a 1.20% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Neonc Technologies Price Performance

Shares of NTHI opened at $3.68 on Monday. Neonc Technologies Holdings, Inc. has a 52-week low of $3.01 and a 52-week high of $12.99. The stock has a 50 day moving average price of $4.07 and a 200 day moving average price of $5.36.

Neonc Technologies (NASDAQ:NTHI) last issued its earnings results on Monday, August 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Analyst Ratings Changes

A number of analysts recently issued reports on NTHI shares. BTIG Research reissued a “buy” rating and issued a $15.00 target price on shares of Neonc Technologies in a research report on Tuesday, September 8th. Alliance Global Partners began coverage on Neonc Technologies in a report on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price objective for the company. Wall Street Zen lowered shares of Neonc Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Maxim Group began coverage on shares of Neonc Technologies in a report on Monday, May 18th. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Weiss Ratings raised shares of Neonc Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 31st. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $16.00.

Institutional Investors Weigh In On Neonc Technologies

Several hedge funds have recently modified their holdings of NTHI. Bank of America Corp DE acquired a new position in Neonc Technologies in the 2nd quarter valued at $1,017,000. BlackRock Inc. purchased a new stake in shares of Neonc Technologies in the second quarter valued at about $815,000. Westmount Partners LLC boosted its holdings in shares of Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after acquiring an additional 153,858 shares in the last quarter. Vanguard Group Inc. acquired a new position in shares of Neonc Technologies during the third quarter worth about $1,279,000. Finally, 683 Capital Management LLC acquired a new position in shares of Neonc Technologies during the fourth quarter worth about $442,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.